貨號(hào)：GS40353

Izenivetmab is an investigational, caninized monoclonal antibody that targets nerve growth factor (NGF). It is specifically developed for veterinary use, primarily in dogs. By binding to and inhibiting NGF, Izenivetmab blocks the pain signaling mediated through this key neurotrophin. It is designed as a long-acting, non-opioid analgesic for the management of chronic pain conditions in dogs, such as osteoarthritis pain, offering a novel mechanism distinct from traditional NSAIDs.